Health MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF July 29, 2026
Health Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering July 28, 2026
Health Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026 July 27, 2026
Search
Health
July 29, 2026
July 29, 2026
July 28, 2026
July 28, 2026
July 28, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
